| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |